Terms: = Colorectal cancer AND SMARCB1, Ini1, 6598, ENSG00000099956, Snr1, SNF5L1, RDT, BAF47, hSNFS, SNF5, INI1, Sfh1p, Q12824
34 results:
1. Identifying regulators of aberrant stem cell and differentiation activity in colorectal cancer using a dual endogenous reporter system.
Spisak S; Chen D; Likasitwatanakul P; Doan P; Li Z; Bala P; Vizkeleti L; Tisza V; De Silva P; Giannakis M; Wolpin B; Qi J; Sethi NS
Nat Commun; 2024 Mar; 15(1):2230. PubMed ID: 38472198
[TBL] [Abstract] [Full Text] [Related]
2. Hafnium (Hf)-Chelating Porphyrin-Decorated Gold Nanosensitizers for Enhanced Radio-Radiodynamic Therapy of Colon Carcinoma.
Li J; Lv Z; Guo Y; Fang J; Wang A; Feng Y; Zhang Y; Zhu J; Zhao Z; Cheng X; Shi H
ACS Nano; 2023 Dec; 17(24):25147-25156. PubMed ID: 38063344
[TBL] [Abstract] [Full Text] [Related]
3. Dedifferentiated and Undifferentiated Ovarian Carcinoma: An Aggressive and Molecularly Distinct Ovarian Tumor Characterized by Frequent SWI/SNF Complex Inactivation.
Tessier-Cloutier B; Kommoss FKF; Kolin DL; Němejcová K; Smith D; Pors J; Stewart CJR; McCluggage WG; Foulkes WD; von Deimling A; Köbel M; Lee CH
Mod Pathol; 2024 Jan; 37(1):100374. PubMed ID: 37925057
[TBL] [Abstract] [Full Text] [Related]
4. Loss of Primary Cilia Potentiates
Remo A; Grillo F; Mastracci L; Simbolo M; Fassan M; Cecchini MP; Miscio G; Sassano A; Parente P; Vanoli A; Sabella G; Giordano G; Urso ED; Cerulo L; Scarpa A; Fiorica F; Pancione M
Genes (Basel); 2023 Apr; 14(5):. PubMed ID: 37239344
[TBL] [Abstract] [Full Text] [Related]
5. smarcb1/ini1-Deficient Poorly Differentiated Carcinoma of the Colon With Rhabdoid Features-A Rare Tumor With Serrated Phenotype: Case Report and Review of Literature.
Maurya S; Yadav S; Bhowmik S; Dhal J; Mehra L; Sharma R; Krishna A; Sharma A; Barwad A; Das P
Int J Surg Pathol; 2024 Feb; 32(1):187-195. PubMed ID: 37128676
[TBL] [Abstract] [Full Text] [Related]
6. [Clinicopathological characteristics of gastric SMARCA4-deficient undifferentiated/rhabdoid carcinoma].
Wu JY; Jiang K; Yan LJ; Yin LS; Huang XZ; Jia L; Sun Y
Zhonghua Bing Li Xue Za Zhi; 2023 May; 52(5):447-453. PubMed ID: 37106285
[No Abstract] [Full Text] [Related]
7. Reactive Oxygen Species as Mediators of Disease Progression and Therapeutic Response in colorectal cancer.
Lyons NJ; Giri R; Begun J; Clark D; Proud D; He Y; Hooper JD; Kryza T
Antioxid Redox Signal; 2023 Jul; 39(1-3):186-205. PubMed ID: 36792932
[No Abstract] [Full Text] [Related]
8. Switch/sucrose-non-fermentable (SWI/SNF) complex (SMARCA4, SMARCA2, ini1/smarcb1)-deficient colorectal carcinomas are strongly associated with microsatellite instability: an incidence study in 4508 colorectal carcinomas.
Ahadi MS; Fuchs TL; Clarkson A; Sheen A; Sioson L; Chou A; Gill AJ
Histopathology; 2022 May; 80(6):906-921. PubMed ID: 34951482
[TBL] [Abstract] [Full Text] [Related]
9. Undifferentiated colonic neoplasm with SMARCA4 germline gene mutation and loss of SMARCA4 protein expression: a case report and literature review.
Duan H; Gao W; Wang L; Cao F; Teng L
Diagn Pathol; 2021 Apr; 16(1):30. PubMed ID: 33836796
[TBL] [Abstract] [Full Text] [Related]
10. NUTM1-rearranged colorectal sarcoma: a clinicopathologically and genetically distinctive malignant neoplasm with a poor prognosis.
Van Treeck BJ; Thangaiah JJ; Torres-Mora J; Stevens TM; Rothermundt C; Fassan M; Loupakis F; Diebold J; Hornick JL; Halling KC; Folpe AL
Mod Pathol; 2021 Aug; 34(8):1547-1557. PubMed ID: 33714983
[TBL] [Abstract] [Full Text] [Related]
11. Panel gene profiling of small bowel adenocarcinoma: Results from the NADEGE prospective cohort.
Aparicio T; Svrcek M; Henriques J; Afchain P; Lièvre A; Tougeron D; Gagniere J; Terrebonne E; Piessen G; Legoux JL; Lecaille C; Pocard M; Gornet JM; Zaanan A; Lavau-Denes S; Lecomte T; Deutsch D; Vernerey D; Puig PL
Int J Cancer; 2021 Apr; 148(7):1731-1742. PubMed ID: 33186471
[TBL] [Abstract] [Full Text] [Related]
12. Cyclin Pathway Genomic Alterations Across 190,247 Solid Tumors: Leveraging Large-Scale Data to Inform Therapeutic Directions.
Jardim DL; Millis SZ; Ross JS; Woo MS; Ali SM; Kurzrock R
Oncologist; 2021 Jan; 26(1):e78-e89. PubMed ID: 32885893
[TBL] [Abstract] [Full Text] [Related]
13. Loss of switch/sucrose non-fermenting complex protein expression in undifferentiated gastrointestinal and pancreatic carcinomas.
Tessier-Cloutier B; Schaeffer DF; Bacani J; Marginean CE; Kalloger S; Köbel M; Lee CH
Histopathology; 2020 Jul; 77(1):46-54. PubMed ID: 32413172
[TBL] [Abstract] [Full Text] [Related]
14. Switch/sucrose nonfermenting nucleosome complex-deficient colorectal carcinomas have distinct clinicopathologic features.
Villatoro TM; Ma C; Pai RK
Hum Pathol; 2020 May; 99():53-61. PubMed ID: 32222462
[TBL] [Abstract] [Full Text] [Related]
15. [Hereditary predisposition to tumors of the central and peripheral nervous systems].
Sourty B; Rousseau A
Ann Pathol; 2020 Apr; 40(2):168-179. PubMed ID: 32192808
[TBL] [Abstract] [Full Text] [Related]
16. Loss of smarcb1 expression in colon carcinoma.
Melloul S; Mosnier JF; Masliah-Planchon J; Lepage C; Le Malicot K; Gornet JM; Edeline J; Dansette D; Texereau P; Delattre O; Laurent Puig P; Taieb J; Emile JF
Cancer Biomark; 2020; 27(3):399-406. PubMed ID: 32083567
[TBL] [Abstract] [Full Text] [Related]
17. CROCC-mutated rhabdoid colorectal carcinoma showing in intercellular spaces lamellipodia and cellular projections revealed by electron microscopy.
Remo A; Cecchini MP; Benati D; Bernardi P; Manfrin E; Giordano G; Bonomi F; Parcesepe P; Fassan M; Colombari R; Sbarbati A; Pancione M
Virchows Arch; 2019 Aug; 475(2):245-249. PubMed ID: 30852641
[TBL] [Abstract] [Full Text] [Related]
18. Molecular characterization of sessile serrated adenoma/polyps with dysplasia/carcinoma based on immunohistochemistry, next-generation sequencing, and microsatellite instability testing: a case series study.
Murakami T; Akazawa Y; Yatagai N; Hiromoto T; Sasahara N; Saito T; Sakamoto N; Nagahara A; Yao T
Diagn Pathol; 2018 Nov; 13(1):88. PubMed ID: 30458818
[TBL] [Abstract] [Full Text] [Related]
19. Comprehensive evaluation of coding region point mutations in microsatellite-unstable colorectal cancer.
Kondelin J; Salokas K; Saarinen L; Ovaska K; Rauanheimo H; Plaketti RM; Hamberg J; Liu X; Yadav L; Gylfe AE; Cajuso T; Hänninen UA; Palin K; Ristolainen H; Katainen R; Kaasinen E; Tanskanen T; Aavikko M; Taipale M; Taipale J; Renkonen-Sinisalo L; Lepistö A; Koskensalo S; Böhm J; Mecklin JP; Ongen H; Dermitzakis ET; Kilpivaara O; Vahteristo P; Turunen M; Hautaniemi S; Tuupanen S; Karhu A; Välimäki N; Varjosalo M; Pitkänen E; Aaltonen LA
EMBO Mol Med; 2018 Sep; 10(9):. PubMed ID: 30108113
[TBL] [Abstract] [Full Text] [Related]
20. Gene mutations in stool from gastric and colorectal neoplasia patients by next-generation sequencing.
Youssef O; Sarhadi V; Ehsan H; Böhling T; Carpelan-Holmström M; Koskensalo S; Puolakkainen P; Kokkola A; Knuutila S
World J Gastroenterol; 2017 Dec; 23(47):8291-8299. PubMed ID: 29307989
[TBL] [Abstract] [Full Text] [Related]
[Next]
